Pfizer announced it has developed a vaccine for the youngest among us (6 mos. to 5 years) and is waiting on approval from the FDA. The shots will be a two-dose regimen.

Dr. Scott Gottlieb, a former FDA commissioner and current Pfizer board member applauded the move.

“If the goal of the vaccine is to get baseline immunity in the kids – to prevent really bad outcomes and you’re really not using the vaccine as a tool to prevent infection in the first place – two doses could do that,” Gottlieb said on CBS’ Face the Nation.


As more young children fall prey to the virus, this is welcome news for parents.







About The Author


Evan Hosie has worked as a Women's Lifestyle editor/writer (expert in the beauty and fashion vertical); created the Pop Culture section for; never met a gadget she didn't want, and spends waaaaay too much time on Social Media.

Related Posts